Dubin Michael F 4
4 · Virpax Pharmaceuticals, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Dubin Michael F
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-01+20,000→ 20,000 totalExercise: $0.62From: 2024-01-01Exp: 2033-01-01→ Common Stock (20,000 underlying)